GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
GILEAD SCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$153.07−3.12 (-2.00%)
Close on Oct 19, 2026
- Market cap
- $190.27B
- P/E (TTM)
- –
- Dividend yield
- 2.06%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$3.16
+2.6% on the prior year
Consecutive increases
11 years
Every year since FY2014
Dividend yield
2.06%
Latest annual dividend ÷ share price
Payout ratio, FY2025
47.0%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $3.16 | +2.6% | $4.00B | 47.0% |
| FY2024 | $3.08 | +2.7% | $3.92B | 816.3% |
| FY2023 | $3.00 | +2.7% | $3.81B | 67.2% |
| FY2022 | $2.92 | +2.8% | $3.71B | 80.8% |
| FY2021 | $2.84 | +4.4% | $3.61B | 57.9% |
| FY2020 | $2.72 | +7.9% | $3.45B | 2804.1% |
| FY2019 | $2.52 | +10.5% | $3.22B | 59.8% |
| FY2018 | $2.28 | +9.6% | $2.97B | 54.5% |
| FY2017 | $2.08 | +13.0% | $2.73B | 59.0% |
| FY2016 | $1.84 | +42.6% | $2.46B | 18.2% |
| FY2015 | $1.29 | – | $1.87B | 10.3% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.